In recent years, the cell and gene therapy market has grown at a rapid clip. The momentum is likely to continue. According to Vision Research Reports, the global cell and gene therapy market size could hit around $42.56 billion by 2030, growing at a CAGR of 39% from 2022 to 2030. The burgeoning demand in…
Enzyme engineering firm Codexis names new CEO
Codexis (Nasdaq:CDXS) has announced that its board of directors has appointed Dr. Stephen Dilly, former CEO of Sierra Oncology, to be its president and CEO. Dilly will assume the role on August 9, 2022. Former CEO John Nicols will retire to spend more time with his family. Nichols will continue to serve on the Codexis…